Little is known of the persistence and pathogenicity of human herpesvirus 6 (HHV-6) after primary infection, including the role of strain variant. Over 2 to 5 years, 2,716 children and 149 families were studied. Peripheral blood mononuclear cell (PBMC), saliva, and cerebrospinal fluid (CSF) specimens were examined for HHV-6 DNA and variant. Ninety-nine percent of isolates causing primary infection were HHV-6 variant B (HHV-6B), which predominated in 95% -98% of the variants persisting in PBMC and saliva specimens from children and adults. Of 668 CSF samples, 13% contained HHV-6 DNA; of 77 children examined after primary infection, 61% had HHV-6 DNA detected only in their CSF and 39% had HHV-6 DNA in both CSF and PBMCs. HHV-6 variant A (HHV-6A) was detected significantly (P Å .0001) more frequently in CSF than in PBMCs or saliva. In children for whom HHV-6 was identified in both CSF and PBMCs, PBMCs contained only HHV-6B, while CSF contained HHV-6A or HHV-6B, not both. Thus, in patients with dual infection, only HHV-6A persisted in CSF, which suggests that HHV-6A has greater neurotropism. Findings for adults indicate that dual infection occurs; variant persistence is similar to that for children. The frequency of HHV-6A infection increased little with age, thereby indicating that HHV-6A infection remains uncommon into adulthood. This study suggests that HHV-6 variants have different immunobiologic courses and neurotropism.
Human herpesvirus 6 (HHV-6) is a ubiquitous virus causing
The two variants may differ in their ability to maintain lainfection in early childhood, essentially infecting everyone by 3 tency or persistence, in the sites of persistence, and, thus, in years of age [1 -3] . Primary infections produce variable febrile their potential pathogenicity in later life. Giving credence to illnesses, including roseola, and are caused almost exclusively the possibility that the variants have distinct biological characby one of the two strain groups, namely variant B (HHV-6B) teristics is the observation that only one case of clinical primary [1 -4] . In adults, however, the asymptomatic persistence of infection with HHV-6A in a child has been described, despite both HHV-6B and variant A (HHV-6A) has been detected, the isolation of HHV-6A from adults [2 -4]. Hidaka and colthus suggesting that latency of both variants occurs. Reactivaleagues [7] recently described an infant in Japan with acute tion and disease due to HHV-6 infection also have been deroseola in whom HHV-6A infection was identified. Although scribed, primarily in immunocompromised adults [5, 6] . A dithe virus was not isolated from the peripheral blood, HHV-6A rect causal relationship between HHV-6 infection and disease DNA was identified by PCR analysis of the infant's peripheral in adults, however, remains unclear. Little information exists blood mononuclear cells (PBMCs) and CSF during the acute as to (1) how often the primary infection in infancy is followed episode of primary infection. by persistence of the virus and (2) whether the persistence In our long-term prospective studies of children younger continues for subsequent years and may lead to reactivation than 3 years of age who have acute febrile illnesses and present and possible clinical manifestations in adults. It is also unclear to the outpatient facilities at our hospital, we have identified whether new infections occur in subsequent years. ú300 children with symptomatic primary HHV-6 infection via viral isolation and seroconversion [3, 8] . Although four isolates from these children had the phenotypic characteristics of HHV-obtained at the time of evaluation for their febrile illness). similarly but with an additional initial centrifugation at 14,000g for 2 hours at 4ЊC for partial purification of the virus. Nested Family members were similarly followed up to compare the frequency and type of variant persisting in PBMCs and saliva PCR amplification was performed with primer sequences conserved in both variants [3, 13] . Specificity was confirmed with in the parents and children. a probe that hybridizes to both variants by Southern blot hybridization. Ten genomic copies are reliably detected [3] .
Methods
Variant typing was then performed by hybridization with probes for HHV -6A ( 5TGATGAACGGTAAGCGA ) and Patients. From October 1990 to September 1996, children younger than 3 years of age who presented to our emergency HHV-6B (5TGGTGAACGGTCAGCGA). Assays contained HHV-6A-and HHV-6B-positive and -negative controls (inand outpatient facilities because of acute febrile and nonfebrile infections were enrolled in the study if they were previously cluding reaction mixture without DNA), and b-globin primers were coamplified as performance controls to assure that the healthy and were excluded from the study if they had an underlying condition affecting their immune function. A subset of samples contained adequate cellular material and to exclude the presence of inhibitors. the children included in this study who were enrolled from October 1990 to July 1993 were described in previous reports PCR detection of HHV-6 DNA and variant typing were performed on all samples obtained from family members and [3, 10] . However, the previously reported studies did not include the subsequent follow-up and variant data for these pafrom all enrolled children; thus, samples from children with primary infection from whom HHV-6 was isolated by culture tients that we now report in conjunction with data obtained from the children enrolled subsequently and from family memand who seroconverted, children who had not yet acquired HHV-6 infection, and children with prior infection were inbers. At the initial visit, the child's history, results of physical examination, and laboratory findings were recorded, and samcluded in these analyses. Statistical methods. x 2 analyses with use of Epi-Info (Cenples of peripheral blood and CSF (when clinically indicated) were obtained. Children and their family members were then ters for Disease Control and Prevention, Atlanta) were performed for differences in proportions. followed up after each child's physician was contacted. At follow-up visits, enrolled family members were interviewed, and saliva and peripheral blood samples were obtained. The study and consent forms were approved by the Research SubResults ject Review Board of our institution.
Diagnostic criteria. Primary HHV-6 infection was diag-HHV-6 variants of isolates causing primary infections. All 333 HHV-6 isolates from children with primary infection were nosed only when HHV-6 was isolated from the blood and subsequent seroconversion occurred. Children with past priidentified as HHV-6B except three (1%), which were identified as HHV-6A by monoclonal antibody reactivity (table 1) . Subsemary HHV-6 infection were identified by positive PCR analysis of PBMCs or saliva and/or positive serology if the child was quent characterization and variant typing by PCR analysis indicated that these isolates with phenotypic characteristics of 5 months of age or older, the age at which levels of passive maternal antibody would have diminished.
HHV-6A contained a mixture of HHV-6A and HHV-6B genomes. Isolation of HHV-6. PBMCs were separated from anticoagulated blood samples (0.5 -3 mL) by density gradient centrifu-HHV-6 variants in children with previous infection. PCR analyses of 2,716 PBMC samples from all the enrolled children gation (Histopaque 1077; Sigma, St. Louis) and were cocultivated with stimulated cord blood mononuclear cells [8] .
detected the HHV-6 genome in 37% of specimens (table 1) , thus indicating the persistence of HHV-6 following previous Positive cultures were confirmed by indirect immunofluorescence with monoclonal antibodies to HHV-6A or HHV-6B primary infection. Almost all samples (97.5%) were typed as HHV-6B, but slightly more samples from children with previand by PCR analysis [11 -13] . HHV-6 was isolated only from PBMCs.
ous infection (2.5%) were typed as HHV-6A or mixed HHV-6A/HHV-6B than isolates from children with primary Serological testing. IgG antibody to HHV-6 was assayed by indirect immunofluorescence with twofold dilutions of seinfection.
Of 668 CSF samples obtained at the initial evaluation, 84 rum and HSB-2 cells infected with an HHV-6 isolate containing both HHV-6A and HHV-6B genomes [4, 8, 9] .
(13%) contained the HHV-6 genome (table 1) . Of the 84 children for whom CSF samples were positive for HHV-6 DNA Variant-specific DNA PCR oligohybridization. All PCR analyses were run under strict precautions to avoid contaminaby PCR analysis, seven (8.3%) had concurrent viremia from primary infection. HHV-6 DNA was detected in both PBMC tion. All specimens before and after PCR analysis were separated physically, and materials were reserved only for work and CSF samples from 30 of the remaining 77 children (39%). HHV-6 DNA was detected only in CSF samples from the before PCR analysis. DNA from PBMCs was prepared as previously described [8, 10, 13] . Saliva samples were prepared remaining 47 children (61%).
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by site and variant.
Overall, 4% of the PBMC samples from families contained [7] ; these researchers described a 50-day-old Japanese infant with roseola in whom from 84% of children after primary infection, at 2 years in 78%, at 3 years in 78%, and at 4 to 6 years in 57%. HHV-6 HHV-6A infection was identified by detection of HHV-6A DNA in the infant's PBMCs and CSF on the second day of DNA was detected in saliva 6 months to 1 year after primary infection in 70% of the children and after an interval of 2 years illness. Isolation of virus from the infant's PBMCs was not reported. Although serological assays currently cannot differin 33%, 3 years in 67%, and 4 to 6 years in 50%. The variant detected in PBMC and saliva specimens obtained during the entiate between HHV-6A and HHV-6B infection, immunofluorescence assays of this infant's sera were supportive of acute follow-up visits of all the children remained the same. Of the adults whose PBMC samples initially contained the HHV-6 primary HHV-6 infection. The titer of antibody in the acuteand convalescent-phase sera remained unchanged at 1:160 genome, 33% continued to have one or more subsequent samples positive for HHV-6 DNA. Fifteen percent of the followrather than decreasing, as would be characteristic of passively derived maternal antibody. up saliva specimens from adults contained HHV-6 DNA. In three-fourths of these samples, HHV-6 DNA was not consis-
The information on the occurrence and course of infection with HHV-6A is extended by our findings that the rate of tently present but was only intermittently detected.
persistence of HHV-6A in both normal children and adults may be relatively low compared with the rate of persistence Discussion of HHV-6B and that the frequency of HHV-6A infection does not appear to increase with age. Hence, the lack of The findings of this study indicate not only that persistence of HHV-6 DNA occurs in most children in the convalescent identification of HHV-6A infection in infants is not explained by a peak period of acquisition occurring at later phase or the period shortly after primary infection but also that the HHV-6 genome continues to persist over the next 2 to 6 ages, such as generally occurs with human herpesvirus 7 [20] . Why HHV-6A, which is so closely related to HHV-6B years in most normal children. Although HHV-6 DNA was less frequently and consistently detected in PBMC and saliva and human herpesvirus 7, also is not a ubiquitous infection of childhood is unclear. specimens from adults than in those from the children, persistence of HHV-6 also was common in normal adults. A similar HHV-6A infection conceivably could occur in young children at a greater frequency than suspected but be unrecogfrequency of HHV-6 persistence was reported recently by Tanaka-Taya and colleagues [14] in their study of 67 Japanese nized because its clinical manifestations are few or varied. Somewhat against this possibility, however, are our studies children and 28 adults. Overall, HHV-6 DNA was detected in 64% of the throat swab specimens from the children. Of the of primary HHV-6 infection over the past few years at the University of Rochester Medical Center emergency departchildren 12 to 23 months of age, who were likely to have had their primary infection recently, 20 (87%) of 23 had HHV-6 ment and outpatient clinics (Rochester, NY); these studies have now included the examination of ú4,000 children DNA in their throat swab specimens. Of the 14 children between 2 and 8 years of age, 11 (79%) had HHV-6 DNA younger than 3 years of age who have had acute febrile illnesses of varying severity and manifestations and ú500 detected. However, of the 28 adults, only nine (32%) had HHV-6 DNA detected, similar to our findings. normal children without acute illness. Although a PBMC specimen from each child was cultured for HHV-6, none of HHV-6B clearly predominates as the variant persisting in both children and adults. Our findings further suggest that the the HHV-6 isolates obtained was HHV-6A. Hence, HHV-6A, in contrast to HHV-6B, has yet to be isolated from the two variants have distinct immunologic and biological properties and possibly different pathogenic potential. Dual infection peripheral blood of a young child. Another potential explanation is that the differing biological and persistence of both variants at the same and different sites within a normal individual indicate that little or no cross-immucharacteristics of HHV-6A include poorer infectivity, resulting in a less contagious virus. The results for the families in this study nity exists between HHV-6A and HHV-6B despite their genomic similarity [15] . Furthermore, infection with HHV-6A ocmay lend some credence to this explanation, since the number of other family members in whom HHV-6A was detected did not curs in those individuals who have had previous infection with HHV-6B and thus occurs in the presence of good levels of increase when there was a family member shedding HHV-6A in saliva. Another theoretical possibility is that immunity to HHVantibody to HHV-6.
Infection with HHV-6A clearly appears to be much less 6A does not last, and thus signs of previous infection may not remain, thereby suggesting that the HHV-6A detected in these frequent than that with HHV-6B. Although for some time HHV-6A has been found in adults, mostly immunocomprofamilies arose from repeated asymptomatic reinfections. If HHV-6A does not evoke adequate immunity, the finding mised patients (including the patient with the first reported case of HHV-6 infection) [12, 16 -19] , primary infection in infants of its relative predominance in the CSF may be more ominous / 9c43$$ja76 11-24-97 22:37:37 cidas UC: CID ence of HHV-6 in the CNS is not generally feasible, particularly may require a prospective evaluation over decades.
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